000 01104 a2200301 4500
005 20250514020115.0
264 0 _c20011231
008 200112s 0 0 eng d
022 _a1471-2598
024 7 _a10.1517/14712598.1.1.3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBhatia, V
245 0 0 _aNovel approaches to allogeneic stem cell therapy.
_h[electronic resource]
260 _bExpert opinion on biological therapy
_cJan 2001
300 _a3-15 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aGraft vs Host Disease
650 0 4 _aHematopoietic Stem Cell Transplantation
_xmethods
650 0 4 _aHumans
650 0 4 _aLeukemia
_xtherapy
650 0 4 _aMyeloablative Agonists
_xtherapeutic use
650 0 4 _aRecurrence
650 0 4 _aTransplantation, Homologous
_xmethods
700 1 _aPorter, D L
773 0 _tExpert opinion on biological therapy
_gvol. 1
_gno. 1
_gp. 3-15
856 4 0 _uhttps://doi.org/10.1517/14712598.1.1.3
_zAvailable from publisher's website
999 _c11641588
_d11641588